Budget for 'pharmacy of the world': What Sitharaman & Co can do to make medicines more affordable in India

Union Budget 2026: India's pharmaceutical landscape is on the brink of a transformative boom. To maintain this upward trajectory, the focus must shift towards fostering innovation and enhancing the efficiency of drug manufacturing. Strategic government funding is essential to bolster research initiatives, support production facilities, and strengthen healthcare frameworks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fv9FTCQ
via IFTTT